Abeona Therapeutics News

Abeona Therapeutics Analyst Ratings

BenzingaApr 23 08:45 ET

Abeona Therapeutics Analyst Ratings

BenzingaAug 24, 2023 11:49 ET

Cantor Fitzgerald Reiterates Overweight on Abeona Therapeutics, Maintains $38 Price Target

BenzingaJul 13, 2023 08:56 ET

Abeona Therapeutics Analyst Ratings

BenzingaJul 13, 2023 08:55 ET

Analysts Have Conflicting Sentiments on These Healthcare Companies: Ascendis Pharma (ASND) and Abeona Therapeutics (ABEO)

TipRanksNov 14, 2022 15:50 ET

SVB Leerink Maintains Market Perform on Abeona Therapeutics, Raises Price Target to $6

Benzinga Real-time NewsNov 14, 2022 13:46 ET

Cantor Fitzgerald Adjusts Price Target on Abeona Therapeutics to $40 From $22, Maintains Overweight Rating

MT NewswiresNov 8, 2022 11:47 ET

Cantor Fitzgerald Maintains Overweight on Abeona Therapeutics, Raises Price Target to $40

Benzinga Real-time NewsNov 8, 2022 11:32 ET

Abeona Therapeutics (ABEO) Gets a Hold From SVB Securities

TipRanksNov 6, 2022 22:30 ET

Alliance Global Starts Abeona Therapeutics at Buy With $20 Price Target

MT NewswiresSep 15, 2022 08:28 ET

SVB Securities Keeps Their Hold Rating on Abeona Therapeutics (ABEO)

TipRanksAug 11, 2022 16:50 ET

Abeona Therapeutics Is Maintained at Market Perform by SVB Leerink

Dow JonesAug 11, 2022 14:10 ET

Abeona Therapeutics Price Target Raised to $5.00/Share From $1.00 by SVB Leerink

Dow JonesAug 11, 2022 14:10 ET

SVB Leerink Maintains Market Perform on Abeona Therapeutics, Raises Price Target to $5

Benzinga Real-time NewsAug 11, 2022 14:00 ET